Scholarlink

Active surveillance (AS) for papillary thyroid microcarcinoma (cT1aN0M0; PTMC) was initiated in 1993 in Kuma Hospital (Kobe, Japan), and it has passed over 30 years. Since it was adopted by the guidelines conducted by the American Thyroid Association in 2015, and since then, many manuscripts reporting favorable outcomes of patients have been published from countries other than Japan. In this chapter, we stated the outcomes of AS and compared the prognosis between patients with AS and those with immediate surgery from various aspects such as patients’ selection, prognosis, and quality of life.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Active Surveillance for Low-Risk Papillary Thyroid Microcarcinoma

  • 章节

  • 发表日期：

    2026年

查看全文
  • Yasuhiro Ito,
  • Akira Miyauchi,
  • Makoto Fujishima

摘要

Active surveillance (AS) for papillary thyroid microcarcinoma (cT1aN0M0; PTMC) was initiated in 1993 in Kuma Hospital (Kobe, Japan), and it has passed over 30 years. Since it was adopted by the guidelines conducted by the American Thyroid Association in 2015, and since then, many manuscripts reporting favorable outcomes of patients have been published from countries other than Japan. In this chapter, we stated the outcomes of AS and compared the prognosis between patients with AS and those with immediate surgery from various aspects such as patients’ selection, prognosis, and quality of life.